DUBLIN–(BUSINESS WIRE)–The “Cell Lysis/Cell Fractionation Market by Product (Consumables (Enzymes, Detergent), Instruments (Sonicators)), Cell Type (Mammalian), Application (Protein Purification), End User (Biopharmaceutical & Biotechnology Companies) – Global Forecast to 2026” report has been added to ResearchAndMarkets.com’s offering.
The global cell lysis market size is projected to reach USD 4.1 billion by 2026 from USD 2.9 billion in 2021, at a CAGR of 7.2% from 2021 to 2026.
Growth in this market is driven by the increasing government funding for research, high prevalence of diseases, and growing focus on personalized medicine.
Consumables segment to witness the highest growth during the forecast period.
Based on the product, the cell lysis market is segmented into consumables and instruments. The consumables segment is projected to grow at the highest CAGR during the forecast period. purchase and high consumption, the high prevalence of diseases, and increasing funding for cell-based research are the major factors supporting the growth of this segment.
Protein purification and isolation segment to register the highest growth in the cell lysis market during the forecast period.
Based on the application, the cell lysis market is segmented into protein purification and isolation, nucleic acid isolation and purification and other application. The protein purification and isolation segment is projected to witness the highest growth in the cell lysis market during the forecast period. The increasing focus on cell-based research, high demand for protein biologics, and extensive proteomic research are the major factors supporting the growth of this segment.
Asia Pacific is estimated to register the highest CAGR during the forecast period.
In this report, the cell lysis market is segmented into four major regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). The market in Asia Pacific is projected to register the highest growth rate during the forecast period. The growth in this market is primarily driven by the government support for vaccine production, increasing funding for cell-based research, low manufacturing costs, and the growing focus of global market players on emerging Asian economies.
Market Dynamics
Drivers
- Increasing Government Funding for Research
- High Prevalence of Diseases
- Growing Focus on Personalized Medicine
Restraints
- High Cost of Cell-Based Research and Instruments
Opportunities
- Emerging Countries
Challenges
- Survival of Small Players and New Entrants
Companies Mentioned
- Agilent Technologies
- Beckman Coulter
- Becton, Dickinson and Company
- Bio-Rad Laboratories
- Biovision
- Cell Signaling Technology
- Claremont Biosolutions
- Covaris
- G-Biosciences (Geno Technology)
- Labfreez Instruments Group
- Merck
- Microfluidics International Corporation
- Miltenyi Biotec
- Norgen Biotek Corp.
- Nzytech
- Parr Instrument Company
- Promega Corporation
- Promocell
- Qiagen
- Qsonica
- Roche Diagnostics
- Stemcell Technologies
- Takara Bio
- Thermo Fisher Scientific
For more information about this report visit https://www.researchandmarkets.com/r/qq1794
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900